[Analysis of Bortezomib-containing combinations in newly-diagnosed multiple myeloma patients: a comparative study]

Zhonghua Xue Ye Xue Za Zhi. 2014 May;35(5):448-50. doi: 10.3760/cma.j.issn.0253-2727.2014.05.015.

[Article in Chinese]

Authors

Lili Xu¹, Huiying Qiu¹, Xiaoxia Hu¹, Shuqing Lyu¹, Xianmin Song¹, Li Chen¹, Weiping Zhang¹, Lei Gao¹, Xiaoqian Xu¹, Jianmin Wang¹, Jianmin Yang¹

Affiliation

¹ Department of Hematology, Changhai Hospital of The Second Mililary Medical University, Shanghai 200433, China.

PMID: 24857218
DOI: 10.3760/cma.j.issn.0253-2727.2014.05.015

No abstract available

Publication types

Comparative Study

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Boronic Acids / administration & dosage*
Bortezomib
Humans
Multiple Myeloma / diagnosis
Multiple Myeloma / drug therapy*
Pyrazines / administration & dosage*

Substances

Boronic Acids
Pyrazines
Bortezomib